revolade.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * | ||
Meta Tags
| Title | Revolade™ (eltrombopag olamine) | |
| Description | It’s Time to Look Beyond Immunosuppression for Sustained REVOLADE® (eltrombopag) is the thrombopoietin receptor agonist (TPO-RA) proven in the most disease states: adult and paediatric chronic immune thrombocytopenia (ITP), adult and paediatric severe aplastic anaemia (SAA), and chronic hepatitis C |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 45.60.154.121 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
revolade.com Valuation
|
US$3,400,838
Last updated: 2023-05-14 10:06:12
revolade.com has Semrush global rank of 3,112,264. revolade.com has an estimated worth of US$ 3,400,838, based on its estimated Ads revenue. revolade.com receives approximately 392,405 unique visitors each day. Its web server is located in United States, with IP address 45.60.154.121. According to SiteAdvisor, revolade.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$3,400,838 |
| Daily Ads Revenue | US$3,140 |
| Monthly Ads Revenue | US$94,178 |
| Yearly Ads Revenue | US$1,130,125 |
| Daily Unique Visitors | 26,161 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| revolade.com. | A | 7199 | IP: 45.60.154.121 |
| revolade.com. | A | 7199 | IP: 45.60.166.121 |
| revolade.com. | NS | 1800 | NS Record: dns3.novartis.com. |
| revolade.com. | NS | 1800 | NS Record: dns1.novartis.com. |
| revolade.com. | NS | 1800 | NS Record: dns4.novartis.com. |
| revolade.com. | NS | 1800 | NS Record: a24-65.akam.net. |
| revolade.com. | NS | 1800 | NS Record: a7-64.akam.net. |
| revolade.com. | NS | 1800 | NS Record: a28-67.akam.net. |
| revolade.com. | NS | 1800 | NS Record: dns2.novartis.com. |
| revolade.com. | NS | 1800 | NS Record: a2-66.akam.net. |
| revolade.com. | NS | 1800 | NS Record: a1-254.akam.net. |
| revolade.com. | NS | 1800 | NS Record: a9-65.akam.net. |
| revolade.com. | TXT | 86400 | TXT Record: _globalsign-domain-verification=LKr333sZ5f2OiNde4sUmJktZl2-0mtzRTTU66RCxYp |
HtmlToTextCheckTime:2023-05-14 10:06:12
| For Health Care Professionals Outside the US US Residents REVOLADE Product Characteristics REVOLADE Product Characteristics --> Safety Information Efficacy ITP Adult ITP Paediatric ITP SAA Chronic HCVaT Platelet response Sustained virologic response Study Designs ITP SAA Chronic HCVaT Safety ITP Most common AEs VTE Bone marrow fibrosis SAA HCVaT Patient Experience Patient Preferences Once-daily Oral Therapy REVOLADE to Other TPO-RAs Why choose REVOLADE Corticosteroids Rituximab Splenectomy Other TPO-RAs MOA Complements Endogenous TPO ITP SAA Immunomodulatory Response Dosing & Administration Dosing and administration Dosing Dietary guidelines Dosing flexibility It’s Time to Look Beyond Immunosuppression for Sustained Response NEW INDICATION Now approved in ITP for use 6 months after diagnosis 1 Now the 1st and Only TPO-RA approved for use in treatment-naive patients with SAA 1 --> COVID-19 has become a major public health challenge around the world. We know that you, and your |
HTTP Headers
HTTP/1.1 301 Moved Permanently Location: https://www.revolade.com/ Content-Length: 0 Connection: close HTTP/2 200 date: Thu, 23 Dec 2021 06:01:19 GMT x-frame-options: DENY x-xss-protection: 1; mode=block x-content-type-options: nosniff content-type: text/html strict-transport-security: max-age=63072000; includeSubdomains; preload last-modified: Fri, 05 Feb 2021 19:19:23 GMT accept-ranges: bytes content-length: 33498 vary: User-Agent set-cookie: TS0161d493=01f27bbbb1b3c51b86db88775fcaf0e390cf646eb78f91b73fc0b0bacbbe936b635b9301a7df3aae1d2aeb6e29b778561a9ac4c676; Path=/; Domain=.www.revolade.com; Secure; HTTPOnly set-cookie: visid_incap_2099768=JNRGeG0lTQKM4SPuWLUHLK8QxGEAAAAAQUIPAAAAAACJ1qMh0xkQxa4IhhmY32xm; expires=Fri, 23 Dec 2022 04:30:54 GMT; HttpOnly; path=/; Domain=.revolade.com set-cookie: incap_ses_702_2099768=yQarPLw7AxdPjBUu5gG+Ca8QxGEAAAAArqvv9YYU0OLBwkN37aHj1w==; path=/; Domain=.revolade.com x-cdn: Imperva x-iinfo: 12-20722745-20722746 NNNN CT(79 158 0) RT(1640239279306 0) q(0 0 2 0) r(3 3) U6 |
revolade.com Whois Information
Domain Name: REVOLADE.COM Registry Domain ID: 176797272_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2021-05-28T09:04:38Z Creation Date: 2005-06-29T18:24:18Z Registry Expiry Date: 2023-06-29T18:24:18Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: A1-254.AKAM.NET Name Server: A2-66.AKAM.NET Name Server: A24-65.AKAM.NET Name Server: A28-67.AKAM.NET Name Server: A7-64.AKAM.NET Name Server: A9-65.AKAM.NET Name Server: DNS1.NOVARTIS.COM Name Server: DNS2.NOVARTIS.COM Name Server: DNS3.NOVARTIS.COM Name Server: DNS4.NOVARTIS.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-26T08:36:39Z <<< |